Tosyl Compounds
-
Subject Areas on Research
- Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.
- Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
- An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.
- Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer.
- Biochemical recurrence of prostate cancer.
- Daily versus as-needed corticosteroids for mild persistent asthma.
- Effect of inhibitors of proteolytic enzymes on the growth of normal and polyoma transformed BHK cells.
- Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.
- Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate.
- Ligand-specific dynamics of the androgen receptor at its response element in living cells.
- Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity.
- Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.
- Regulation of the macrophage population in postnatal rat testis.
- The effect of bretylium tosylate on ventricular function.
- Treating the biochemical recurrence of prostate cancer after definitive primary therapy.
- Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.